What is in GLOW, part by part
Each card comes from that peptide's own reviewed record. None of these records studied the mix.
Copper-binding tripeptide complex
GHK-Cu
EmergingSome studies in people exist. Important questions remain about benefit, safety, who it helps, or how long the effects last. This is not an approval or recommendation.- FDA status
- No FDA-approved injectable GHK-Cu drug product
- Evidence type
- Cell, animal, or product tests
- Results in people
- Limited. Small formulation-specific human studies exist, but broad regenerative and anti-aging outcomes are not established.
- Safety known in people
- Limited. Human information is limited, and FDA identifies injectable immunogenicity and impurity concerns.
- Sports status
- Not assessed
- Last reviewed
- July 23, 2026
A three-amino-acid copper complex with topical and laboratory research. That research does not validate injectable, whole-body, or longevity claims.
Synthetic pentadecapeptide
BPC-157
EmergingSome studies in people exist. Important questions remain about benefit, safety, who it helps, or how long the effects last. This is not an approval or recommendation.- FDA status
- Still being studied; no FDA-approved BPC-157 product identified
- Evidence type
- Health results; use not approved
- Results in people
- Limited. Small uncontrolled pilots cannot establish a patient benefit.
- Safety known in people
- Limited. The human safety dataset is too small for confident risk estimates.
- Sports status
- Prohibited
- Last reviewed
- July 23, 2026
Cell and animal studies, plus small early studies in people, do not prove that BPC-157 heals injuries in people.
Synthetic thymosin beta-4 fragment
TB-500
InsufficientReliable studies in people are missing, too limited, or do not support the claim. This does not prove that the substance has no effect on the body.- FDA status
- No FDA-approved TB-500 drug product
- Evidence type
- Cell, animal, or product tests
- Results in people
- Unclear. FDA found no adequate human clinical outcome evidence for compounded TB-500 wound-healing use.
- Safety known in people
- Unclear. Human exposure and product-specific safety information are inadequate.
- Sports status
- Prohibited
- Last reviewed
- August 1, 2026
A seven-amino-acid piece of thymosin beta-4 promoted for repair, without reliable human healing evidence and with major product and anti-doping limits.
What sellers mean by GLOW
Clinic and telehealth pages from 2026 describe GLOW as three peptides in one vial: GHK-Cu, BPC-157, and TB-500. They describe KLOW as the same three plus KPV.
The name sets no fixed amount or ratio. Sellers list different totals, and a total for the whole vial does not show each peptide's share.
Sources: KLOW peptide stack (with GLOW) · GLOW peptide: GHK-Cu, BPC-157, TB-500 blend explained · KLOW peptide (with notes on GLOW and Glow drips)
A Glow IV drip is a different product
Med spas also sell a Glow drip. One clinic page describes it as an IV mix of glutathione and vitamin C, sometimes with B vitamins, and no peptides.
The peptide records below do not apply to that drip. Read the label or ask the seller for the full ingredient list.
Has anyone tested GLOW?
On October 13, 2026, a PubMed search for all three peptides together returned 6 papers. None tested the three together in people or animals.
The closest study tested two of the three parts. In a 2026 rat study, BPC-157 and TB-500 given together did no better for tendon repair than either one alone.
Sources: PubMed search: BPC-157, TB-500, and GHK-Cu · Effects of BPC-157 and TB-500 on Achilles tendon healing in rats
The GHK-Cu evidence comes from skin products
One clinic says GLOW is aimed at skin and tissue repair. GHK-Cu's human record found here is one small study of a product put on the skin after laser treatment. It found no clear gain over the comparison group in measured redness, wrinkles, or skin quality.
GLOW is sold as a vial, and a skin product study does not show what an injected peptide does. FDA has flagged possible immune reactions and limited human data for injected GHK-Cu.
Sources: KLOW peptide stack (with GLOW) · Topical GHK-Cu after laser resurfacing (randomized study) · Bulk drug substances that may present significant safety risks
Questions to ask about your vial
A seller name does not answer these. The label and records do.
- 01
Is your product a peptide vial or an IV drip with the same name?
- 02
Which peptides are in your exact vial, and how much of each?
- 03
Was the GHK-Cu study you read about skin cream or a shot?
- 04
Did the study test people, animals, or cells?
Fact checks for each part
Each result covers one peptide and the exact statement shown. It does not cover the mix.
GHK-Cu
“GHK-Cu has been studied in people.”
“Topical GHK-Cu evidence proves injectable GHK-Cu works systemically.”
“Injectable GHK-Cu is proven safe.”
BPC-157
“BPC-157 improves tendon healing in preclinical models.”
“BPC-157 heals tendons and muscles in people.”
“Athletes can use it because it is not a steroid.”
TB-500
“TB-500 is the same thing as thymosin beta-4.”
“TB-500 accelerates tendon and muscle healing in people.”
“TB-500 is allowed in tested sport.”
Sports rules for each part
These statuses do not give personal clearance to compete.
GHK-Cu
This editorial review did not determine sport eligibility. Athletes must check the current prohibited list, Global DRO, and their governing body.
ReviewedRoute and formulation are part of the claim. This guide does not provide injectable-use, compounding, cosmetic-treatment, or wound-care instructions.
BPC-157
BPC-157 is listed under WADA's S0 non-approved substances category and is prohibited at all times for covered athletes.
ReviewedThe site will not provide self-injection, reconstitution, dosing, sourcing, or stack instructions. “Research use only” does not establish quality or make a product appropriate for human use.
TB-500
TB-500 is named as a prohibited thymosin-beta-4 derivative on the 2026 WADA Prohibited List and is prohibited at all times for covered athletes.
ReviewedThis is not an invitation to experiment. The guide provides no sourcing, reconstitution, injection, cycle, stack, or injury-treatment instructions.
What remains unknown
- No study reports side effects of GLOW as a mix.
- The records do not show whether the three peptides change each other's effects.
- The site gives no amounts, mixing, injection, or sourcing directions for any part.
The site does not provide dosing, sourcing, or treatment advice.
Read the sources
About the GLOW blend
GHK-Cu record
BPC-157 record
TB-500 record